We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

TxCell Announces Publication of Preclinical Efficacy Results for Col-Treg

News   Sep 10, 2015

 
TxCell Announces Publication of Preclinical Efficacy Results for Col-Treg
 
 
 

RELATED ARTICLES

Additional Evidence Shows HPV Vaccine is Safe

News

Further evidence has been generated to demonstrate the safety of the life-saving bivalent HPV vaccine.

READ MORE

UK-India Project Combats Infections Threat with Diagnostics

News

A £3 million interdisciplinary research project is to address the growing threat of drug-resistant infections in India.

READ MORE

T Cell Study Uncovers New Hurdle for Developing Immunotherapies

News

There's an unexpected challenge to be overcome - T cell receptors can be more cross-reactive than previously thought.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE